Acute Episodes of Vertigo(the wind-phlegm syndrome)
Conditions
Interventions
treatment group:Banxia Baizhu Tianma formula particles (Shineway brand)
control group:Banxiabaizhu Tianma Decoction (traditional herbs decoction)
Sponsors
Shijiazhuang Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Meet Western diagnostic criteria of posterior circulation ischemia; (2) Meet the vertigo diagnostic criteria of Chinese medicine; (3) In line with the syndrome of the wind-phlegm syndrome of TCM syndrome in acute episodes of vertigo (can be combined with other syndromes), have not received any for the treatment of vertigo light, moderate patients (level of stun grading 0-III level); (4) 18 years old to 80 years old, male or female; (5) Patients or their families with informed consent, and signed Informed Consent Forms.
Exclusion criteria
Exclusion criteria: (1) Except posterior circulation ischemia other diseases such as: intracranial space-occupying lesions, brain trauma, brain inflammation, cervical spondylosis, ear diseases such as Meniere's disease, labyrinthitis, vestibular neuron inflammation, chain Mycotoxin and other diseases caused by vertigo; (2) Dizziness caused by transient ischemic attack (TIA); (3) Significant depression, severe neurological deficits can not complete the examination, such as coma, a variety of aphasia, audio-visual disorders; (4) Those who can not swallow oral drugs, or suffering from diseases that affect the absorption of oral drugs, such as active bowel disease, partial or complete intestinal obstruction; (5) Severe circulatory, respiratory, urinary, digestive, hematopoietic (eg unstable angina, uncontrollable asthma, active gastric bleeding, etc.) and cancer; (6) Severe bleeding tendency and liver and kidney dysfunction (aminotransferase more than 1.5 times the upper limit of normal, creatinine clearance = 133mmol/L); (7) Pregnancy, lactation or pregnancy may be pregnant and planning patients; (8) Participate in other clinical studies or participate in other clinical studies within 3 months prior to the date of informed consent; (9) Researchers think it inappropriate to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improve TCM syndrome score before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| The improvement of the comprehensive effect of vertigo before and after treatment (integral of vertigo symptom + main complication symptom score);The improvement of vertigo symptom scores before and after treatment;UCLA vertigo scale before and after treatment;Drugs to drug recurrence rate of 4 weeks;Drugs to drug recurrence rate of 12 weeks; | — |
Countries
China
Contacts
Public ContactJianjing Yao
Shijiazhuang Hospital of Traditional Chinese Medicine
Outcome results
None listed